Sodium-glucose co-transporter 2 inhibitor canagliflozin modulates myocardial metabolism and inflammation in a swine model for chronic myocardial ischemia is a research paper published in Surgery (2023). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: T32HL160517
National Heart, Lung, and Blood Institute
Grant: 1F32HL160063-01
National Heart, Lung, and Blood Institute
Grant: R01HL128831
National Heart, Lung, and Blood Institute
Grant: R01HL46716
National Heart, Lung, and Blood Institute
Grant: R56HL133624-05
National Heart, Lung, and Blood Institute
Grant: T32 GM065085-10
NHLBI NIH HHS
Grant: F32 HL160063
NHLBI NIH HHS
Grant: R01 HL085647
NHLBI NIH HHS
Grant: R25 HL088992
NHLBI NIH HHS
Grant: T32 HL076130
NIGMS NIH HHS
Grant: T32 GM065085
NIGMS NIH HHS
Grant: P20 GM103652
NHLBI NIH HHS
Grant: R01 HL133624
NHLBI NIH HHS
Grant: R56 HL133624
NHLBI NIH HHS
Grant: R01 HL046716
FWCI
1.62
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals